SCHEMBL26423604

SCHEMBL26423604

c1ccc2nc3sc4ccncc4c3cc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
GLA P06280 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 2/20 0.38
ACHE P22303 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
CLK1 P49759 1/20 0.37
KDM4E B2RXH2 4/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
POLB P06746 3/20 0.37
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37
PTBP1 P26599 1/20 0.37
KMT2A Q03164 1/20 0.37
RCE1 Q9Y256 1/20 0.37
CYP2A6 P11509 3/20 0.36
CHEK2 O96017 1/20 0.35
FLT1 P17948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11716295 0.82 GPR3 (0.46) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL26423627 0.81 CLK1 (0.40) ALDH1A1HPGDMAPTCLK1KDM4E
SCHEMBL26423611 0.81 CLK1 (0.40) ALDH1A1HPGDMAPTCLK1KDM4E
SCHEMBL25461773 0.80 RAB9A (0.46) ALDH1A1HPGDMAPTKDM4ENPC1
SCHEMBL26423665 0.79 NPC1 (0.38) ALDH1A1MAPTACHECLK1KDM4E
SCHEMBL26423609 0.78 ALDH1A1 (0.38) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL26423546 0.77 KDM4E (0.39) ALDH1A1HPGDMAPTACHECLK1
SCHEMBL26423726 0.76 CYP2A6 (0.33) CYP2A6
SCHEMBL25462132 0.76 RAB9A (0.42) ALDH1A1HPGDMAPTKDM4ENPC1
SCHEMBL25548063 0.75 KDM4E (0.44) ALDH1A1GLAHPGDMAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 ALDH1A1 302/4885GLA 2547/4885HPGD 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.